Navigation Links
The Friendship Stone Helps Friends Remain Healthy
Date:7/22/2009

Founder of My Stone Company and Crohn’s Disease sufferer dedicates Friendship Week to her friends and family who accelerated her recovery. Lack of friends connected to poorer health Company aims to reduce number of lonely people in America.

New York, NY (Vocus) July 22, 2009 –- My Stone Company, creators of The Friendship Stone will mark Friendship Week starting August 2nd. Founder, Cathy Raff, will dedicate the week to her friends and family for helping her recover from numerous complications from Crohn’s Disease and for being the inspiration behind The Friendship Stone (www.thefriendshipstone.com). In addition, during Friendship Week, My Stone Company aims to reduce the number of lonely people across America through reminding people of the importance and benefits of friendships and remaining positive.

Friendship has been shown to enhance one’s health and Cathy is proof of this. She suffered for more than thirty years with Crohn’s Disease. She had multiple, serious health issues which included twelve hospitalizations and five major surgeries within an intense five-year period. She regained her health by bonding with and drawing on her friends and family. Her recovery motivated her to establish her own company and produce its first product, The Friendship Stone, to create these connections in others.

“It is estimated that about one in five of us Americans suffer from loneliness,” said Jill Raff, Cathy’s sister and spokesperson for The Friendship Stone. “Knowing that there is one person in the world that is looking out for you, believes in you and supports you, can make a tremendous difference in one’s life. Our goals are high, but this Friendship Week we hope to reduce the number of lonely people in our country. If everyone
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. New Ads Provide Glimpse Into Unique Friendship Between Aflac Duck and Carl Edwards
2. Three Women in Health Crises Go Online to Form Lifelong Friendships : Mothers of Boys with Cancer Find Support, Encouragement and Each Other at CarePages.com
3. New Friendship Cottage Cheese Boosts Digestive & Bone Health
4. PA Cyber Sponsors Conference on Helping Children With Autism Form Friendships
5. Community Hospitals: Dying Breed or Community Cornerstone?
6. Cornerstone Therapeutics David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal
7. Explorers Bounty Unveils New Line of Tribal Stone Crackers
8. Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product
9. HHS Secretary Sebelius Highlights Michigans MHA Keystone Center in Inaugural Health Care Success Story Report
10. Sunesis Pharmaceuticals Receives Milestone Payment From Biogen Idec
11. Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The Friendship Stone Helps Friends Remain Healthy
The Friendship Stone Helps Friends Remain Healthy
(Date:12/2/2009)...cent of low-income mothers who participated in a r...trong general feeling of distrust of the opposite ...d not prevent them from entering into a marriage, ...e union was often later described by some of the w... of distrust and insecurity. The results of the st...
(Date:12/2/2009)...h cholesterol and become obese? The same way as pe... , More importantly, according to two new studie...uit flies use the same molecular mechanisms as hum...l and a key form of stored fat that contributes to...y to learn more about the genetic and biological p...
(Date:12/2/2009)..., a leading vendor of Internet-based chronic disea...rsion of its software offering. The new release n... and weight management capabilities in addition to... Acton, MA. (PRWEB) December...Internet-based chronic disease management software...
(Date:12/2/2009)...ire-FirstCall/ -- US Farms, Inc. (Pink Sheets: USF... Wellness products, is pleased to announce it will...k,sware A,faire in Oakland, Calif., at the Oakland... information, contact US Farms, Inc. Customer Serv...okswareafaire.com ,, Victor Brandstetter, US F...
(Date:12/2/2009)...Dec. 3 ,, Head of Army,s Warrior Transition C...d Warriors; Army Embraces Reality of ,Unseen Injur... 2 The following was re...ility: ,, WHAT: Wounded veterans and career c...ram,s National Organization on Disability,s Career...
Breaking Medicine News(10 mins):Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2
...st cancer have warned others to be wary of the mam... given a clean diagnosis in spite of having cancer...ast, Phillipa Naismith, 52, and Sandra Harley, 48,...lia's top litigation firms, Maurice Blackburn Cash...
...nfirmed that their studies on bacteria that bunch ...ad and persistent ear infections// that irritate k...s against these conditions is pointless. Oti...ne. It was explained that some are cases of acute ...
...e University of Texas, Southwestern Medical Center...he necessity of a caesarean section //in pregnant ...e UT Southwestern study is the first large-scale c...s in this month's issue of the journal Obstetrics ...
...e leading developmental disability. Statistics sho...r from autism. In US there is a 10-17% increase in...sease has been studied widely and its symptoms kno...an of the Department of Cognitive and Neural Syste...
...ces, differences in the treatment given to male an...blems persist, a new study has found//. In a...en to benefit from hospitals' quality-improvement ...ttack survivors live longer and healthier lives. ...
...fers from Hodgkin's disease, a cancer of the lymph...t on his neck that turned out to be a swollen lymp...led that he also had a tumor near his windpipe. Th...e cancer cells. After two months active cancer cel...
Other Medicine News:Health News:BreastScreen Australia Is Being Sued Towards Medical Negligence 2Health News:‘Biofilms’-Clumped Bacterial Slime Cause Ear Infecti 2Health News:Valtrex Prevents the Need for C-Section among Women Infected With Genital Herpes 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 2Health News:iSTART Brain Model Reveals the possible Cause of Autism 3Health News:Heart Attack Care Continues To Be Biased In Favor Of Men 2Health News:Heart Attack Care Continues To Be Biased In Favor Of Men 3Health News:US Boy Wants the Right of Choice of Treatment 2
(Date:12/2/2009)...c. 2 Novartis announced today that...on Tasigna® (nilotinib) 200 mg capsules in a ...strength of the company,s hematology portfolio in ...a, at the 51st American Society of Hematology (ASH...pany,s current therapies and investigational agent...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Medical Oxygen Systems - Global Market Op...0164334/Medical-Oxygen-Systems---Global-Market-Opp...stems market for home healthcare setting is reckon...wth expectations stem from demographic factors suc...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Molecular Diagnostics - A World Market Rev...olecular-Diagnostics---A-World-Market-Review.html ...n by several growth factors that include the need ... combine optimized sample preparation, analysis, a...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 1OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 1Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 3Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 1Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 2Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 3
...J., Oct. 29 Sanofi-aventis,announced today that t...d,Apidra(R) (insulin glulisine [rDNA origin] injec...ears and older) with diabetes mellitus., The appr...FDA review of,a 26-week, phase III, open-label, ac... insulin lispro, in 572 children and adolescents (...
..., Oct. 29 CuraGen Corporation,(Nasdaq: CRGN ), a...on,oncology, announced today that Company executiv...t 11:00 a.m. ET on Monday, November 3, 2008,follow...sults and to review,preliminary data from CuraGen,...for the treatment of advanced melanoma., Data fro...
Other Medicine Technology:FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 2FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 3FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 4FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 5CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008 2
Shandon Pathcentre Tissue Processor
Shandon Excelsior Tissue Processor
Shandon Grosslab Junior Grossing Workstation
Shandon Hyperclean 2 Fume Handling Station
Medicine Products: